Dorit Leshem‐Lev

747 total citations
35 papers, 559 citations indexed

About

Dorit Leshem‐Lev is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Dorit Leshem‐Lev has authored 35 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 9 papers in Surgery. Recurrent topics in Dorit Leshem‐Lev's work include Angiogenesis and VEGF in Cancer (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Platelet Disorders and Treatments (5 papers). Dorit Leshem‐Lev is often cited by papers focused on Angiogenesis and VEGF in Cancer (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Platelet Disorders and Treatments (5 papers). Dorit Leshem‐Lev collaborates with scholars based in Israel and United States. Dorit Leshem‐Lev's co-authors include Ran Kornowski, Eli I. Lev, Edith Hochhauser, Alexander Battler, Leor Perl, Tamir Bental, Noa Zemer‐Wassercug, Muthiah Vaduganathan, Eldad Rechavia and Dror Fixler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Blood.

In The Last Decade

Dorit Leshem‐Lev

34 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dorit Leshem‐Lev Israel	16	228	174	112	92	78	35	559
Brian P. Davidson United States	20	218 1.0×	119 0.7×	224 2.0×	48 0.5×	50 0.6×	41	903
Ruqiong Nie China	16	201 0.9×	228 1.3×	128 1.1×	22 0.2×	25 0.3×	56	665
Mohammad Qadura Canada	17	178 0.8×	299 1.7×	322 2.9×	177 1.9×	60 0.8×	88	940
Magdolna Nagy Netherlands	15	194 0.9×	128 0.7×	102 0.9×	278 3.0×	124 1.6×	49	701
Aneta Radziwon‐Balicka Denmark	14	75 0.3×	177 1.0×	68 0.6×	101 1.1×	51 0.7×	19	518
Paul‐Eduard Neagoe Canada	16	151 0.7×	234 1.3×	71 0.6×	65 0.7×	21 0.3×	30	622
Tony G. Walsh United Kingdom	13	108 0.5×	139 0.8×	50 0.4×	167 1.8×	32 0.4×	21	564
Shuanglun Xie China	16	260 1.1×	190 1.1×	118 1.1×	13 0.1×	23 0.3×	51	641
Sunil X. Anand United States	7	155 0.7×	39 0.2×	126 1.1×	68 0.7×	85 1.1×	8	366
Friedgard Julmy Switzerland	12	222 1.0×	97 0.6×	197 1.8×	180 2.0×	53 0.7×	14	617

Countries citing papers authored by Dorit Leshem‐Lev

Since Specialization

Citations

This map shows the geographic impact of Dorit Leshem‐Lev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorit Leshem‐Lev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorit Leshem‐Lev more than expected).

Fields of papers citing papers by Dorit Leshem‐Lev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorit Leshem‐Lev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorit Leshem‐Lev. The network helps show where Dorit Leshem‐Lev may publish in the future.

Co-authorship network of co-authors of Dorit Leshem‐Lev

This figure shows the co-authorship network connecting the top 25 collaborators of Dorit Leshem‐Lev. A scholar is included among the top collaborators of Dorit Leshem‐Lev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorit Leshem‐Lev. Dorit Leshem‐Lev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zadok, Osnat Itzhaki Ben, et al.. (2024). Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies. SHILAP Revista de lepidopterología. 20. 100896–100896. 1 indexed citations

Leshem‐Lev, Dorit, Sabina Winograd‐Katz, Inbar Nardi Agmon, et al.. (2024). Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia. British Journal of Haematology. 205(3). 1011–1016. 2 indexed citations

Agmon, Inbar Nardi, et al.. (2024). The effect of empagliflozin on circulating endothelial progenitor cells in patients with diabetes and stable coronary artery disease. Cardiovascular Diabetology. 23(1). 386–386. 1 indexed citations

Leshem‐Lev, Dorit, et al.. (2022). Reticulated Platelets and Their Relationship with Endothelial Progenitor Cells during the Acute Phase of ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 11(21). 6597–6597.

Zadok, Osnat Itzhaki Ben, Dorit Leshem‐Lev, Tuvia Ben‐Gal, et al.. (2021). The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis. Cardiovascular Drugs and Therapy. 36(3). 489–496. 1 indexed citations

Zadok, Osnat Itzhaki Ben, Aviv Mager, Dorit Leshem‐Lev, et al.. (2021). The Effect of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors on Circulating Endothelial Progenitor Cells in Patients with Cardiovascular Disease. Cardiovascular Drugs and Therapy. 36(1). 85–92. 15 indexed citations

Talmor‐Barkan, Yeela, Chava Chezar‐Azerrad, Dorit Leshem‐Lev, et al.. (2020). Elevated galectin-3 in women with gestational diabetes mellitus, a new surrogate for cardiovascular disease in women. PLoS ONE. 15(6). e0234732–e0234732. 15 indexed citations

Eisen, Alon, Dorit Leshem‐Lev, Hagai Yavin, et al.. (2015). Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study). Cardiovascular Drugs and Therapy. 29(2). 129–135. 16 indexed citations

Vaduganathan, Muthiah, Noa Zemer‐Wassercug, Eldad Rechavia, et al.. (2015). Relation between ticagrelor response and levels of circulating reticulated platelets in patients with non-ST elevation acute coronary syndromes. Journal of Thrombosis and Thrombolysis. 40(2). 211–217. 18 indexed citations

10.

Zemer‐Wassercug, Noa, Moti Haim, Dorit Leshem‐Lev, et al.. (2015). The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers. Journal of Thrombosis and Thrombolysis. 40(3). 340–346. 23 indexed citations

11.

Eisen, Alon, Leor Perl, Eldad Rechavia, et al.. (2014). Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor. Journal of Thrombosis and Thrombolysis. 40(1). 70–75. 21 indexed citations

12.

Perl, Leor, Eldad Rechavia, Muthiah Vaduganathan, et al.. (2013). Response to Prasugrel and Levels of Circulating Reticulated Platelets in Patients With ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology. 63(6). 513–517. 72 indexed citations

13.

Hochhauser, Edith, Austin M. Guo, Katherine Gotlinger, et al.. (2013). Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. Prostaglandins & Other Lipid Mediators. 100-101. 15–21. 46 indexed citations

14.

Blum, Arnon, et al.. (2012). Endothelial Progenitor Cells Are Suppressed in Anemic Patients with Acute Coronary Syndrome. The American Journal of Medicine. 125(6). 604–611. 21 indexed citations

15.

Hochhauser, Edith, Ran Kornowski, Dorit Leshem‐Lev, et al.. (2012). Endothelial Progenitor Cell Function Inversely Correlates With Long-term Glucose Control in Diabetic Patients: Association With the Attenuation of the Heme Oxygenase-Adiponectin Axis. Canadian Journal of Cardiology. 28(6). 728–736. 28 indexed citations

16.

Vaturi, Mordehay, Leor Perl, Dorit Leshem‐Lev, et al.. (2011). Circulating Endothelial Progenitor Cells in Patients With Dysfunctional Versus Normally Functioning Congenitally Bicuspid Aortic Valves. The American Journal of Cardiology. 108(2). 272–276. 19 indexed citations

17.

Leshem‐Lev, Dorit, et al.. (2010). Adenosine A1 and A3 receptor agonists reduce hypoxic injury through the involvement of P38 MAPK. Molecular and Cellular Biochemistry. 345(1-2). 153–160. 16 indexed citations

18.

Raiter, Annat, et al.. (2010). Angiogenic Peptides Improve Blood Flow and Promote Capillary Growth in a Diabetic and Ischaemic Mouse Model. European Journal of Vascular and Endovascular Surgery. 40(3). 381–388. 11 indexed citations

19.

Lev, Eli I., Dorit Leshem‐Lev, Aviv Mager, et al.. (2010). Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis. European Heart Journal. 31(21). 2625–2632. 35 indexed citations

20.

Leshem‐Lev, Dorit, Alexander Omelchenko, Leor Perl, et al.. (2010). Exposure to platelets promotes functional properties of endothelial progenitor cells. Journal of Thrombosis and Thrombolysis. 30(4). 398–403. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact